Consortium 'ready' to buy ailing Morecambe
The Shrimps were suspended by the National League until 20 August on Monday over failing to comply with the league's rules.
Panjab Warriors have been in talks with the club's owner Jason Whittingham for over a year and a deal had looked set to be concluded earlier this summer.
They have now said in a joint-statement with minority shareholders, the Shrimps Trust and Lizzi Collinge MP that the National League is ready to sanction the deal and "immediately lift the suspension and embargo should it be agreed".
BBC investigates takeover turmoil behind Morecambe suspension
Morecambe suspended from the National League
Morecambe owner 'not heard from' potential bidder
As it stands, Morecambe's fixture away to Boston United on 9 August, their first home game against Brackley Town on 16 August, and the trip to Scunthorpe United on 19 August, will no longer take place as scheduled.
Whittingham, who has been looking to sell the club since 2022, announced a new buyer, named as a consortium led by Jonny Cato, had been found earlier in July, but it remains unclear where that bid also stands.
Whittingham said on Sunday he had "not heard from" Panjab Warriors in the past week and talks with Cato were ongoing.
The Lancashire side, who were promoted to League One in 2021, were relegated from League Two last season - their second relegation in the past three seasons.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Physitrack Announces Commercial Partnership with Leading UK Rehabilitation Provider Pure Physiotherapy
LONDON, UK / / July 31, 2025 / Physitrack PLC (STO:PTRK) has entered into a commercial partnership with Pure Physiotherapy, one of the UK's leading providers of musculoskeletal (MSK) services, recognised for its nationwide clinical network and large-scale delivery of both NHS and private sector physiotherapy. Pure Physiotherapy delivers evidence-based, outcome-driven MSK care to a diverse population - from private patients seeking specialist physiotherapy to tens of thousands of NHS patients through its extensive First Contact Practitioner (FCP) services. With a rapidly expanding footprint and a reputation for clinical excellence, Pure is a key player in modernising access to physiotherapy across the UK. Under the new agreement, Pure will implement Physitrack's digital health platform across its national clinic network, enabling tailored exercise prescription, remote patient monitoring, and improved clinical engagement. The collaboration aligns with Pure's focus on leveraging technology to deliver scalable, high-quality care that meets both NHS and private sector standards. "We are delighted to be bolstering our relationship with Physitrack, knowing what a valuable tool this is for patients and clinicians alike and look forward to further technological developments in terms of data and tracking to really evidence what a fantastic service we provide. We are excited about further insights into our own service, as well as contributing to the wider data picture around the benefits of Physiotherapy to the population of the UK, both within the NHS and private sector and can see Physitrack as one of the services which helps us fulfil that ambition," said Alison Day, Director of Clinics, Pure Physiotherapy. Henrik Molin, CEO of Physitrack, commented: "Pure Physiotherapy is a standout provider in the UK MSK landscape - combining strong NHS partnerships with a growing private care offering. We're proud to support their commitment to delivering effective, digitally enabled care across communities and clinical settings. The subscription agreement, valued initially at £14,000 per annum and expected to scale significantly with further clinic adoption, marks a strategic advance in Physitrack's UK growth - particularly among leading MSK providers operating at the interface of public and private healthcare. A Spotlight newsroom interview with CEO Henrik Molin on the subject is available here: Enquiries regarding this announcement should be addressed to: Henrik Molin, CEO and co-founder, Physitrack.+44 208 133 9325ir@ About Physitrack Physitrack PLC, founded in 2012, is a global digital healthcare provider, focused on the B2B wellness and virtual-first care markets. With staff with 12 nationalities on four continents, customers in 17 time zones, and end users in 187 countries, Physitrack is a truly global company. The company has two business lines:1. Lifecare - SaaS platform tailored mainly to physiotherapy and musculoskeletal care, enabling practitioners to deliver clinical home exercises, education prescription, outcomes tracking, triaging and Telehealth.2. Wellness / Champion Health - SaaS platform for Employee Wellness and care powered by a combination of world-leading technology and wellness professionals based in the United Kingdom, Germany and the Nordics. Physitrack PLC is headquartered in London, United Kingdom, and listed on Nasdaq First North Premier Growth Market (PTRK). Visit us athttps:// (investor relations) (product marketing) About Champion Health Champion Health, a subsidiary of Physitrack Plc, is a leader in corporate wellness technology, providing an innovative platform that empowers businesses to support their employees' well-being through personalised wellness action plans and advanced analytics. Visit us athttps:// Attachments Physitrack Announces Commercial Partnership with Leading UK Rehabilitation Provider Pure Physiotherapy SOURCE: Physitrack PLC View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
26 minutes ago
Ahead of Friday deadline, appeals court considering lawfulness of Trump's sweeping tariffs
As the clock ticks down to President Donald Trump's Aug. 1 deadline for the resumption of reciprocal tariffs, a federal appeals court is hearing arguments Thursday over whether Trump's sweeping tariffs are lawful. A group of small businesses and a coalition of states are asking the U.S. Court of Appeals for the Federal Circuit to invalidate the bulk of Trump's tariffs, arguing that Trump overstepped his power when he used a decades-old economic emergency statute to enact a flurry of tariffs in April. "The President's chaotic assertion of that purported authority, which changed by the day and wreaked havoc on capital markets and the economy, illustrates both the breadth of powers that the President claims and the danger of unlimited authority in this domain," the coalition of states argued in their brief to the court. The hearing comes at a critical time for Trump, as he rushes to complete trade deals ahead of a self-imposed Friday deadline for dozens of reciprocal tariffs to restart. Lawyers for the Trump administration have argued that a court invalidating the tariffs would create a "foreign policy disaster scenario" as trade negotiations remain ongoing. "To all of my great lawyers who have fought so hard to save our Country, good luck in America's big case today," Trump wrote on his social media platform Thursday morning. "If our Country was not able to protect itself by using TARIFFS AGAINST TARIFFS, WE WOULD BE 'DEAD,' WITH NO CHANCE OF SURVIVAL OR SUCCESS." The legal authority for Trump's tariffs was thrown into uncertainty in May when the New York-based Court of International Trade ruled that the president did not have the power to unilaterally impose his global "Liberation Day" tariffs, as well as the tariffs on China, Mexico, and Mexico that Trump imposed to combat fentanyl trafficking. A federal appeals court quickly stayed the Court of International Trade's decision before it could take effect, while the Trump administration's appeal worked its way through the courts. At issue is whether Trump had the authority to enact tariffs without authorization from Congress through the International Emergency Economic Powers Act, which gives the president the power to impose tariffs under an "unusual and extraordinary threat." While the Trump administration has argued that the tariffs combat fentanyl trafficking and seek to settle the country's trade imbalances, the Court of International Trade was unconvinced that the Trump administration demonstrated an "unusual and extraordinary threat" and that those tariffs "deal with the threats." In court filings, the Trump administration has argued that court's decision is "riddled with legal errors" and "would significantly harm the United States if it were to take effect." They have justified the tariffs by citing the country's fentanyl crisis and the "grave threats to the United States' national security and economy" stemming from trade imbalances. "President Trump has found that America's exploding trade deficit, the implications of that deficit for our economy and national security, and a fentanyl importation crisis that has claimed thousands of American lives constitute national emergencies," lawyers with the Department of Justice have argued. The Trump administration has also argued that invalidating the tariffs would "deprive the United States of a powerful tool for combating systemic distortions in the global trading system, thus allowing other nations to continue to hold American exporters hostage to their unreasonable, discriminatory, and sometimes retaliatory trade policies." The group of small businesses and state attorneys general have pushed back against those claims, arguing that the International Emergency Economic Powers Act does not give Trump "unlimited tariff authority" and that he has failed to prove "an unusual and extraordinary threat." "The President's chaotic assertion of that purported authority, which changed by the day and wreaked havoc on capital markets and the economy, illustrates both the breadth of powers that the President claims and the danger of unlimited authority in this domain," they wrote.
Business Wire
26 minutes ago
- Business Wire
Bahlam Capital Provides Mezzanine Loan to Doselva P.B.C.
GRANADA, Nicaragua--(BUSINESS WIRE)--Bahlam Capital ('Bahlam'), a Central American-based private equity firm focused on transformational growth opportunities, announced that it provided growth capital in the form of a mezzanine loan to Doselva Public Benefit Corporation ('Doselva' or 'the Company'). Having local fund managers who understand the region's challenges and opportunities is critical for businesses like ours. Since the investment, Doselva has continued to expand its operations across Nicaragua and Honduras, sourcing organic turmeric, ginger, cardamom, allspice, lemongrass, and vanilla from hundreds of smallholder farmers. The Company aggregates, processes, and exports these spices to leading U.S. brands. With a focus on traceability, quality, and sustainability, Doselva has earned a reputation as a trusted supplier to blue-chip buyers. In a region where agricultural value chains are often fragmented and opaque, Doselva's vertically-integrated model offers a rare combination of reliability, scale, and impact. Beyond its role as a reliable exporter, Doselva creates meaningful impact by helping farmers earn significantly higher incomes than they would with traditional crops. The Company also provides technical training and agronomic support, helping farmers adopt more sustainable and productive practices. 'We look for companies that have demonstrated resilience in challenging environments, and Doselva is a great example of that,' said Michael Barjum, Managing Partner at Bahlam Capital. 'We know how difficult it can be to operate in Central America and backing entrepreneurs like Jefferson is one of the reasons we launched Bahlam.' Jefferson Shriver, CEO of Doselva, commented, 'Bahlam's operating experience and strong network in Central America made them an ideal partner. Having local fund managers who understand the region's challenges and opportunities is critical for businesses like ours.' This is Bahlam's first investment in Nicaragua. The firm continues to deepen its footprint across the region through targeted investments that combine operational rigor with long-term development potential. 'We remain deeply committed to Central America and firmly believe that private capital—applied strategically—is vital to the region's development,' added Barjum. 'Investors occasionally ask us whether Bahlam is impact-focused or return-driven. Bahlam is a commercial fund manager first, but our track record shows that generating strong returns and fostering positive impact are not mutually exclusive endeavors. Our investment in Doselva is proof of that.' About Doselva Founded in 2017, Doselva is dedicated to producing and exporting high-quality organic spices from Central America. Working with over 300 smallholder farmers, the company promotes regenerative agroforestry practices by offering technical support, inputs, and guaranteed market access. Doselva's model improves rural livelihoods while advancing sustainable agriculture. For more: About Bahlam Capital Founded in 2023, Bahlam provides transformational capital to mid-sized companies across Central America. The firm identifies, funds, and executes on the most promising growth opportunities for companies in the region. Bahlam seeks businesses at an inflection point, eager to expand their commercial offering or move up the value-creation chain, focusing on four main sectors: business services, consumer, manufacturing, and agro-processing. The firm combines operational rigor with local insights to drive value. Bahlam has offices in Tegucigalpa, Honduras, and Boston, Massachusetts. For more: or follow us at
